CTI BioPharma Corp. EBITDA Margin 2010-2023 | CTIC
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for CTI BioPharma Corp. (CTIC) over the last 10 years. The current EBITDA margin for CTI BioPharma Corp. as of March 31, 2023 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2023-03-31 | $0.08B | $-0.05B | -69.33% |
| 2022-12-31 | $0.05B | $-0.08B | -147.17% |
| 2019-09-30 | $0.02B | $-0.03B | -182.35% |
| 2019-06-30 | $0.02B | $-0.04B | -225.00% |
| 2019-03-31 | $0.02B | $-0.04B | -229.41% |
| 2018-12-31 | $0.03B | $-0.03B | -122.22% |
| 2018-09-30 | $0.01B | $-0.05B | -361.54% |
| 2018-06-30 | $0.01B | $-0.04B | -314.29% |
| 2018-03-31 | $0.04B | $-0.03B | -71.43% |
| 2017-12-31 | $0.03B | $-0.04B | -160.00% |
| 2017-09-30 | $0.03B | $-0.03B | -91.18% |
| 2017-06-30 | $0.04B | $-0.05B | -130.56% |
| 2017-03-31 | $0.02B | $-0.07B | -338.10% |
| 2016-12-31 | $0.06B | $-0.05B | -85.71% |
| 2016-09-30 | $0.06B | $-0.07B | -118.97% |
| 2016-06-30 | $0.06B | $-0.07B | -132.73% |
| 2016-03-31 | $0.05B | $-0.09B | -173.47% |
| 2015-12-31 | $0.02B | $-0.12B | -725.00% |
| 2015-09-30 | $0.02B | $-0.13B | -560.87% |
| 2015-06-30 | $0.06B | $-0.09B | -143.55% |
| 2015-03-31 | $0.06B | $-0.08B | -135.48% |
| 2014-12-31 | $0.06B | $-0.08B | -140.00% |
| 2014-09-30 | $0.08B | $-0.03B | -45.33% |
| 2014-06-30 | $0.04B | $-0.06B | -162.86% |
| 2014-03-31 | $0.03B | $-0.05B | -141.18% |
| 2013-12-31 | $0.03B | $-0.04B | -114.71% |
| 2010-12-31 | $0.00B | $-0.08B | inf% |
| 2010-06-30 | $0.00B | $-0.10B | inf% |
| 2010-03-31 | $0.00B | $-0.10B | inf% |
| 2009-12-31 | $0.00B | $-0.09B | inf% |
